We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
(+14%)
Cap. Flow
+$7.27B
Cap. Flow
% of AUM
9.7%
Top 10 Holdings %
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.04B |
| 2 |
Microsoft
MSFT
|
+$830M |
| 3 |
Amazon
AMZN
|
+$550M |
| 4 |
Johnson & Johnson
JNJ
|
+$483M |
| 5 |
Apple
AAPL
|
+$470M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$474M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$435M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$428M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$371M |
| 5 |
Micron Technology
MU
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 13.75% |
| 3 | Healthcare | 12.4% |
| 4 | Financials | 7.81% |
| 5 | Industrials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Ironwood Pharmaceuticals
IRWD
$626M
| $1.42M | ﹤0.01% |
217,218
-355,282
| -62% | -$2.51M |
|
1502
Eagle Bancorp
EGBN
$866M
| $1.41M | ﹤0.01% |
+74,640
| New | +$1.45M |
|
1503
Cable One
CABO
$249M
| $1.41M | ﹤0.01% |
+3,984
| New | +$1.52M |
|
1504
Avantor
AVTR
$8.48B
| $1.41M | ﹤0.01% |
66,399
-1,759,545
| -96% | -$42.4M |
|
1505
Gladstone Capital
GLAD
$436M
| $1.41M | ﹤0.01% |
60,472
-12,195
| -17% | -$266K |
|
1506
Archrock
AROC
$6.19B
| $1.41M | ﹤0.01% |
69,582
-137,780
| -66% | -$2.73M |
|
1507
Oil-Dri
ODC
$1.48B
| $1.41M | ﹤0.01% |
43,866
+14,728
| +51% | +$541K |
|
1508
Resideo Technologies
REZI
$5.55B
| $1.41M | ﹤0.01% |
+71,861
| New | +$1.49M |
|
|
ADVM
1509
DELISTED
Adverum Biotechnologies
ADVM
| $1.4M | ﹤0.01% |
204,619
+70,768
| +53% | +$658K |
|
1510
Howard Hughes
HHH
$4B
| $1.4M | ﹤0.01% |
22,716
+5,833
| +35% | +$366K |
|
|
CDMO
1511
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $1.4M | ﹤0.01% |
+195,461
| New | +$1.5M |
|
1512
Valmont Industries
VMI
$9.33B
| $1.39M | ﹤0.01% |
5,070
-3,592
| -41% | -$876K |
|
1513
State Street SPDR S&P Insurance ETF
KIE
$671M
| $1.39M | ﹤0.01% |
+27,910
| New | +$1.4M |
|
1514
TechnipFMC
FTI
$28.9B
| $1.39M | ﹤0.01% |
+53,140
| New | +$1.37M |
|
1515
Kosmos Energy
KOS
$1.39B
| $1.39M | ﹤0.01% |
250,735
+124,058
| +98% | +$724K |
|
|
XFINW
1516
CALL
DELISTED
ExcelFin Acquisition Corp Warrant
XFINW
| $1.39M | ﹤0.01% |
126,266
| – | – |
|
1517
Nuveen Churchill Direct Lending
NCDL
$624M
| $1.38M | ﹤0.01% |
79,467
+10,493
| +15% | +$185K |
|
|
GTACW
1518
CALL
DELISTED
Global Technology Acquisition Corp. I Warrant
GTACW
| $1.37M | ﹤0.01% |
120,000
-309,791
| -72% | -$28.2K |
|
|
HOUS
1519
DELISTED
Anywhere Real Estate
HOUS
| $1.37M | ﹤0.01% |
+412,569
| New | +$1.93M |
|
1520
Repay Holdings
RPAY
$344M
| $1.37M | ﹤0.01% |
+129,263
| New | +$1.32M |
|
|
FSP
1521
Franklin Street Properties
FSP
$50.1M
| $1.36M | ﹤0.01% |
890,682
+180,324
| +25% | +$339K |
|
1522
Scorpio Tankers
STNG
$3.94B
| $1.36M | ﹤0.01% |
+16,724
| New | +$1.28M |
|
1523
Samsara
IOT
$21.9B
| $1.35M | ﹤0.01% |
40,121
-22,479
| -36% | -$775K |
|
1524
Orion Group Holdings
ORN
$485M
| $1.34M | ﹤0.01% |
141,344
-79,518
| -36% | -$703K |
|
1525
Bank of Hawaii
BOH
$3.17B
| $1.34M | ﹤0.01% |
+23,495
| New | +$1.36M |
|
Similar funds
Marshall Wace's Q2 2024 Portfolio in Review
As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.
- Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
- Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
- Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
- Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
- Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.
Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.